Literature DB >> 7149113

Antibody- and cell-mediated immune resistance by guinea pigs to adult Amblyomma americanum ticks.

S J Brown.   

Abstract

Naive and actively and passively sensitized guinea pigs were infested with adult Amblyomma americanum ticks. Naive hosts allowed for 75-81% tick yield, 518-581 mg mean tick weight and an average tick feeding period of 12-13 days. Actively sensitized and challenged hosts, however, allowed only 47% tick yield (38.9% rejection), replete individuals were significantly reduced in weight (66.1% weight decrease) and required slightly longer time to feed (14 days). Passively sensitized hosts were given either serum or peritoneal exudate cells (PEC) harvested from actively sensitized and challenged guinea pigs which had expressed resistance. Recipients of immune serum allowed 56% tick yield (27.3% rejection), replete individuals had a mean weight of 376 mg (35.3% reduction) and required an average feeding period of 15 days. However, recipients of immune PEC were conferred with stronger protection allowing only 50% tick yield (35.1% rejection) with a mean tick weight of 413 mg (28.9% reduction) and females required an average feeding period of 15 days to become replete. Cutaneous cellular responses to tick feeding in naive animals were dominated by neutrophils in both female and male attachment sites (62-64%), with the cellular response (lesion) in female sites being 10 times that of male sites. In actively sensitized and challenged (resistant) hosts, cutaneous cellular responses to both females and males were dominated by basophils (53-59%), and lesion size was nearly 20 times greater than in primary feedings, indicating heightened sensitivity to tick bite.

Entities:  

Mesh:

Year:  1982        PMID: 7149113     DOI: 10.4269/ajtmh.1982.31.1285

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

Review 1.  Immunology of interactions between ticks and laboratory animals.

Authors:  J R Allen
Journal:  Exp Appl Acarol       Date:  1989-06       Impact factor: 2.132

2.  A Histopathologic Study of the Human Skin in the Early Stage After a Tick Bite: A Special Reference to Cutaneous Tissue Reaction to the Cement Substance of Tick Saliva.

Authors:  Motoyuki Mihara
Journal:  Yonago Acta Med       Date:  2017-09-15       Impact factor: 1.641

3.  Feeding performance of Amblyomma variegatum (Acarina: Ixodidae) fed repeatedly on rabbits.

Authors:  A A Latif; R M Newson; T S Dhadialla
Journal:  Exp Appl Acarol       Date:  1988-09       Impact factor: 2.132

4.  Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance.

Authors:  Sukanya Narasimhan; Cheyne Kurokawa; Husrev Diktas; Norma Olivares Strank; Jiří Černý; Kristen Murfin; Yongguo Cao; Geoff Lynn; Jos Trentleman; Ming-Jie Wu; Kathy DePonte; Fred Kantor; Juan Anguita; Joppe Hovius; Erol Fikrig
Journal:  Ticks Tick Borne Dis       Date:  2020-01-03       Impact factor: 3.744

5.  Effect of host age on the expression of acquired resistance to ticks.

Authors:  S J Brown
Journal:  Experientia       Date:  1984-02-15

Review 6.  The role of saliva in tick feeding.

Authors:  Ivo M B Francischetti; Anderson Sa-Nunes; Ben J Mans; Isabel M Santos; Jose M C Ribeiro
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 7.  Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface.

Authors:  Mária Kazimírová; Saravanan Thangamani; Pavlína Bartíková; Meghan Hermance; Viera Holíková; Iveta Štibrániová; Patricia A Nuttall
Journal:  Front Cell Infect Microbiol       Date:  2017-07-26       Impact factor: 5.293

Review 8.  Vaccination against Lyme disease: past, present, and future.

Authors:  Monica E Embers; Sukanya Narasimhan
Journal:  Front Cell Infect Microbiol       Date:  2013-02-12       Impact factor: 5.293

9.  Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism.

Authors:  S Urioste; L R Hall; S R Telford; R G Titus
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.